A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection
Sustained CD4+ T cell immunity is required for resolution of acute hepatitis C virus (HCV) infection, but the response remains poorly characterized. Here, circulating CD4+ T cells with high programmed cell death 1 (PD-1) and ICOS coexpression were temporally associated with onset of virus control, seroconversion, and hepatitis in HCV-infected chimpanzees. Coproduction of T follicular helper (Tfh) (IL-21 and CXCL13) and Th1 (IFN-γ and TNF) cytokines after stimulation with HCV nonstructural proteins demonstrated that the response was predominately Tfh1 like and virus specific. Transcriptional analysis verified a Tfh1 lineage assignment. Effector-related genes such as ADGRG1 (GPR56), ZNF683 (Hobit), and KLRB1 (CD161) were also expressed. HCV-specific PD-1hiICOShi CD4+ Tfh1-like cells were enriched in liver, suggesting the potential for B and CD8+ T cell help at the site of virus replication. Most circulating and intrahepatic PD-1hiICOShi CD4+ Tfh1-like cells did not express CXCR5 and therefore resembled CXCR5-CXCL13+ peripheral helper cells that infiltrate tumors and tissues inflamed by autoimmunity. PD-1hiICOShi CD4+ Tfh1-like cells also peaked after hepatitis A virus infection, but the response was accelerated by several weeks compared with HCV infection. The PD-1hiICOShi phenotype and temporal association between the peak response and alanine aminotransferase may provide markers to guide human studies of CD4+ T cell immunity against HCV and other hepatotropic viruses.
Authors
- Christopher C. Phelps (ORCID: https://orcid.org/0000-0003-4545-5650)
- Zhaohui Xu (ORCID: https://orcid.org/0000-0003-0645-1737)
- Nicole Skinner (ORCID: https://orcid.org/0000-0003-4807-022X)
- Arash Grakoui (ORCID: https://orcid.org/0000-0002-6002-7518)
- William G. Bremer
- Naglaa H. Shoukry (ORCID: https://orcid.org/0000-0002-8817-8238)
- Heather Blasczyk (ORCID: https://orcid.org/0000-0002-0485-3591)
- Yan Zhou (ORCID: https://orcid.org/0000-0003-4793-7303)
- David Geoffrey Bowen (ORCID: https://orcid.org/0000-0002-7965-5581)
- Robert E. Lanford (ORCID: https://orcid.org/0000-0003-4980-2920)
- Christopher M. Walker (ORCID: https://orcid.org/0000-0003-1580-1620)
Institutions
- Texas Biomedical Research Institute (US)
- Nationwide Children's Hospital (US)
- Emory University (US)
- Emory and Henry College (US)
- Foundation for Advancing Veterans Health Research (US)
- Centre Hospitalier de l’Université de Montréal (CA)
- The Ohio State University (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1172/jci178089
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Emory University
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases